Ever wondered whether we should sequence the DNA of all newborns at birth to detect disease early? Check out our latest work from the
#NBSeq project where we benchmark the performance of exome sequencing as a population-level newborn screen for inherited metabolic disorders.
Whole-exome sequencing is not sensitive or specific enough to replace mass spectrometry screening of rare inborn errors of metabolism, but can help to reduce false positives and facilitate the resolution of ambiguous cases
@berkeleyMCB @UCSFMedicine go.nature.com/3fRUHgS